×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Fredun Pharmaceuticals Limited | 1,026.97 | 53.33 | 1,018.41 | 11.29 | 322.0 | 17.1 |
| GENNEX LABORATORIES LTD. | 400.06 | 50.65 | 377.07 | 0.22 | 321 | 17.2 |
| OXYGENTA PHARMACEUTICAL LIMITE | 336.94 | -39.28 | 332.06 | 1.12 | 299 |
Fredun Pharmaceuticals Limited, with Security Code 539730, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 68.8 | 77.6 | 79.7 | 61.2 | 81.4 | 86.6 | 117.2 | 77.5 | 106.8 | 101.8 |
| Expenses | 63.5 | 70.6 | 67.5 | 54.4 | 72.4 | 76.5 | 106.9 | 68.3 | 93.4 | 89.5 |
| Operating Profit | 5.3 | 7.0 | 12.2 | 6.8 | 9.1 | 10.2 | 10.3 | 9.2 | 13.5 | 12.4 |
| OPM % | 7.72% | 9.01% | 15.28% | 11.09% | 11.17% | 11.73% | 8.83% | 11.87% | 12.62% | 12.15% |
| Other Income | 1.5 | 0.3 | 0.1 | 0.8 | 0.5 | 0.4 | 0.8 | 1.3 | 0.5 | 0.9 |
| Interest | 1.9 | 2.0 | 3.6 | 2.6 | 2.9 | 3.8 | 4.4 | 3.9 | 5.3 | 5.0 |
| Depreciation | 0.7 | 0.7 | 0.7 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 |
| Profit before tax | 4.2 | 4.6 | 8.0 | 4.1 | 5.8 | 5.8 | 5.8 | 5.5 | 7.6 | 7.1 |
| Tax % | 25.2% | 25.2% | 51.4% | 41.1% | 31.8% | 26.7% | 13.3% | 25.2% | 43.6% | 25.3% |
| Net Profit | 3.2 | 3.5 | 3.9 | 2.4 | 3.9 | 4.2 | 5.1 | 4.1 | 4.3 | 5.3 |
| EPS in Rs | 7.11 | 7.66 | 8.59 | 5.24 | 8.4 | 8.99 | 10.77 | 8.79 | 9.05 | 11.29 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 29% |
| 3 Years: | 38% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 28% |
| 3 Years: | 98% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 28% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|